EVOLV-Rx: Optimizing Medication Management for Older Adults through Data-Driven Deprescribing
EVOLV-Rx is a specialized software tool designed to detect low-value prescribing (LVP) practices within healthcare datasets, specifically targeting older adult populations. By identifying ineffective or potentially harmful medication use, the tool empowers clinicians to prioritize deprescribing and significantly reduce the risks of adverse drug events.
Description
EVOLV-Rx functions by utilizing a curated set of the 18 most scientifically valid and clinically useful LVP practices, which were established via an expert Delphi Panel alongside patient and caregiver input. The software applies sophisticated algorithms across diverse administrative healthcare data, including ICD-10 diagnosis codes, CPT codes, National Drug Codes (NDCs), and patient sociodemographic variables. This comprehensive data integration allows the tool to accurately identify the prevalence of problematic prescribing habits that lead to polypharmacy. The system is designed to integrate seamlessly with existing electronic clinical decision support platforms. Once integrated, it provides physicians, nurse practitioners, and pharmacists with actionable insights to identify high-impact deprescribing opportunities. By focusing on medications where discontinuation is most likely to be acceptable to patients, the technology bridges the gap between clinical data and person-centered care.Applications
- Clinical Decision Support (CDS): Integration into Electronic Health Record (EHR) systems to provide real-time alerts to providers at the point of care.- Health Insurance and Payers: Development of policies and interventions to address high-cost, low-value medication use within insured populations.
- Long-Term Care Management: Monitoring and optimizing prescribing practices within nursing facilities and assisted living environments.
- Health Services Research: A tool for researchers to study factors associated with LVP and the effectiveness of large-scale deprescribing interventions.
- Pharmacy Benefit Management (PBM): Assisting pharmacists in identifying and prioritizing candidates for medication therapy management and dose reduction.
Advantages
- Clinically Validated Prioritization: Consolidates and prioritizes 18 critical LVP practices from over 500 global recommendations, reducing the time burden on clinicians.- Enhanced Patient Safety: Targets the reduction of polypharmacy and hyper-polypharmacy to prevent falls, delirium, hospitalizations, and death.
- Patient-Centered Design: Incorporates the views of patients and caregivers regarding medication burdens and costs, ensuring high acceptability of clinical recommendations.
- Operational Efficiency: Automates the identification of prescribing issues, saving valuable time for healthcare teams during routine clinical practice.